Eric H Chan, MD in La Jolla, CA - Medicare Ophthalmology

Eric H Chan, MD is a medicare enrolled "Ophthalmology - Glaucoma Specialist" physician in La Jolla, California. He went to University Of California, Geffen School Of Medicine and graduated in 2015 and has 9 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Riverside Medical Clinic Inc and his current practice location is 9415 Campus Point Dr, La Jolla, California. You can reach out to his office (for appointments etc.) via phone at (800) 926-8273.

Eric H Chan is licensed to practice in California (license number A160341) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1427443316.

Contact Information

	Eric H Chan, MD
	9415 Campus Point Dr, La Jolla, CA 92093
	(800) 926-8273
	(888) 539-8781

Physician's Profile

Full Name	Eric H Chan
Gender	Male
Speciality	Ophthalmology
Experience	9 Years
Location	9415 Campus Point Dr, La Jolla, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Eric H Chan attended and graduated from University Of California, Geffen School Of Medicine in 2015

NPI Data:

NPI Number: 1427443316
Provider Enumeration Date: 03/30/2015
Last Update Date: 06/24/2019

Medicare PECOS Information:

PECOS PAC ID: 7315272010
Enrollment ID: I20190717003618

Medical Identifiers

Medical identifiers for Eric H Chan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427443316	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207WX0009X	Ophthalmology - Glaucoma Specialist	A160341 (California)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Riverside Medical Clinic Inc	2961492327	149

News Archive

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Indian drug manufacturer, Ranbaxy Pharmaceuticals has tentative approval from the U.S. Food and Drug Administration to manufacture and market Glimepiride Tablets, 3 mg and 6 mg.

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

ViroPharma Incorporated today announced that the European Medicines Agency (EMA) has accepted the filing of its Marketing Authorization Application for Cinryze for acute treatment and prophylaxis against hereditary angioedema, which was submitted through the centralized procedure in March 2010. ViroPharma is seeking European approval for both prevention and treatment of acute attacks of hereditary angioedema.

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

Pennsylvania state departments remind parents to never leave children alone in cars

The departments of Human Services (DHS) and Health today reminded Pennsylvanians to never leave children alone in cars, which could prove deadly after only a few minutes.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Eric H Chan allows following entities to bill medicare on his behalf.

Entity Name	Faculty Physicians And Surgeons Of Llusm
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1205009917 PECOS PAC ID: 1153227814 Enrollment ID: O20031211000981

News Archive

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Indian drug manufacturer, Ranbaxy Pharmaceuticals has tentative approval from the U.S. Food and Drug Administration to manufacture and market Glimepiride Tablets, 3 mg and 6 mg.

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

Pennsylvania state departments remind parents to never leave children alone in cars

The departments of Human Services (DHS) and Health today reminded Pennsylvanians to never leave children alone in cars, which could prove deadly after only a few minutes.

Read more Medical News

› Verified 1 days ago

Entity Name	Regents Of The University Of California
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1699877621 PECOS PAC ID: 3577476761 Enrollment ID: O20040219000974

News Archive

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Indian drug manufacturer, Ranbaxy Pharmaceuticals has tentative approval from the U.S. Food and Drug Administration to manufacture and market Glimepiride Tablets, 3 mg and 6 mg.

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

Pennsylvania state departments remind parents to never leave children alone in cars

The departments of Human Services (DHS) and Health today reminded Pennsylvanians to never leave children alone in cars, which could prove deadly after only a few minutes.

Read more Medical News

› Verified 1 days ago

Entity Name	Riverside Medical Clinic Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1720183403 PECOS PAC ID: 2961492327 Enrollment ID: O20040517000880

News Archive

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Indian drug manufacturer, Ranbaxy Pharmaceuticals has tentative approval from the U.S. Food and Drug Administration to manufacture and market Glimepiride Tablets, 3 mg and 6 mg.

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

Pennsylvania state departments remind parents to never leave children alone in cars

The departments of Human Services (DHS) and Health today reminded Pennsylvanians to never leave children alone in cars, which could prove deadly after only a few minutes.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eric H Chan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Eric H Chan, MD Po Box 232410, San Diego, CA 92193-2410 Ph: () -	Eric H Chan, MD 9415 Campus Point Dr, La Jolla, CA 92093 Ph: (800) 926-8273

News Archive

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Indian drug manufacturer, Ranbaxy Pharmaceuticals has tentative approval from the U.S. Food and Drug Administration to manufacture and market Glimepiride Tablets, 3 mg and 6 mg.

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

Pennsylvania state departments remind parents to never leave children alone in cars

The departments of Human Services (DHS) and Health today reminded Pennsylvanians to never leave children alone in cars, which could prove deadly after only a few minutes.

Ophthalmology Doctors in La Jolla, CA

David Scott Michelson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9834 Genesee Ave, Suite 200, La Jolla, CA 92037 Phone: 858-457-3050 Fax: 858-457-0851
Dr. Leah Levi, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, Scripps Clinic Ms214, La Jolla, CA 92037 Phone: 858-554-7996
Dr. Eric Leung, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 9415 Campus Point Dr, Mc 0946, La Jolla, CA 92093 Phone: 773-213-1110
Dr. Jose Ivan Quiceno, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, Scmg Division Of Ophthalmology, La Jolla, CA 92037 Phone: 858-554-9108
Dr. Robyn Grossman Cohen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9834 Genesee Avenue, Suite 315, La Jolla, CA 92037 Phone: 858-457-4090 Fax: 858-457-1543
Mr. Tomas M Grippo, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Shiley Eye Center, 9415 Campus Point Drive, Rm 217 Mc 0946, La Jolla, CA 92093 Phone: 917-679-7782
Shagun Kumari Bhatia, MD, MSCR Ophthalmology Medicare: Medicare Enrolled Practice Location: 9415 Campus Point Dr, La Jolla, CA 92093 Phone: 588-534-2020

Eric H Chan, MD - Medicare Ophthalmology in La Jolla, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Pennsylvania state departments remind parents to never leave children alone in cars

Medicare Reassignments

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Pennsylvania state departments remind parents to never leave children alone in cars

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Pennsylvania state departments remind parents to never leave children alone in cars

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Pennsylvania state departments remind parents to never leave children alone in cars

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Pennsylvania state departments remind parents to never leave children alone in cars

Ophthalmology Doctors in La Jolla, CA